PHC Stay Cell Metabolic Analyzer (LiCellMo) Receives 2024 Innovation Award from The Analytical Scientist

Article content material

TOKYO — The Biomedical Division of PHC Company (Headquarters: Chiyoda-ku, Tokyo, Japan; President: Nobuaki Nakamura), has obtained a 2024 Innovation Award from The Analytical Scientist¹ for its reside cell metabolic analyzer, LiCellMo^TM. LiCellMo, launched for analysis use in Japan in September and america, UK, EU, China and different Asian choose geographies in October², offers repeatedly measured knowledge on key mobile metabolic pathways³, giving researchers a exact image of beforehand unobservable modifications within the state of cells over time and permitting them to make extra knowledgeable analysis selections. This can assist contribute to novel analysis findings and vital advances in therapies. It’s designed to disclose mobile metabolic mechanisms and enhance the reproducibility and high quality of cell cultures within the growth of producing processes for cell and gene remedy merchandise.

Article content material

Article content material

Article content material

The Analytical Scientist focuses on the folks, know-how and improvements shaping measurement science. The publication points its annual Innovation Awards to acknowledge technical advances which can be positioned to open doorways in analytical sciences.

In analysis for brand new cell and gene therapies (CGT), it’s important to evaluate the state of cells and create an optimum cell tradition atmosphere. LiCellMo permits researchers to visualise metabolic modifications in cell cultures in actual time, offering a extra full image of cell exercise for analysis makes use of in CGT. As a substitute of requiring researchers to take periodic samples of the tradition medium for evaluating cell metabolism, which might make it tough to watch modifications in cell circumstances over time and carries the chance of contamination, LiCellMo offers minute-by-minute measurements of glucose and lactate ranges within the tradition medium. LiCellMo might be simply put in in a laboratory’s present suitable CO₂ incubator with no change to the standard tradition atmosphere. It affords researchers a versatile answer to challenges confronted in typical cell tradition strategies.

PHC Company is a subsidiary of PHC Holdings Company (TOKYO: 6523), a world assortment of healthcare corporations referred to collectively as PHC Group. The in-line monitoring know-how⁴ featured in LiCellMo builds on proprietary know-how from a blood glucose monitoring sensor developed by one other a part of PHC Company, the In Vitro Diagnostics (IVD) Division.

Chikara Takauo, Director of PHC Company and Head of the Biomedical Division, mentioned, “We imagine LiCellMo will give researchers the chance to realize unprecedented new information on cell metabolism, particularly within the fields of most cancers immunology and stem cell analysis, and advance the manufacturing course of for brand new remedies in these fields. This award is a recognition of each the quick contribution of LiCellMo in analysis laboratories and of its promise for supporting the event of future therapies.”

¹ theanalyticalscientist.com/techniques-tools/the-analytical-scientist-innovation-awards-2024-10
² www.phchd.com/international/phc/information/2024/0904
³ A sequence of biochemical reactions inside cultured cells that produce the vitality required for mobile features and survival.
⁴ A know-how that permits steady measurement of mobile metabolites in tradition medium with out the necessity for sampling, achieved by sustaining fixed immersion within the medium.

Article content material

Concerning the Biomedical Division of PHC Company
Established in 1969, PHC Company is a Japanese subsidiary of PHC Holdings Company (TOKYO: 6523), a world healthcare firm that develops, manufactures, sells, and providers options throughout diabetes administration, healthcare options, life sciences and diagnostics. The Biomedical Division helps the life sciences business serving to researchers and healthcare suppliers in round 110 nations and areas by means of its PHCbi-branded laboratory and tools and providers together with CO₂ incubators and ultra-low temperature freezers.
www.phchd.com/international/phc

About PHC Holdings Company (PHC Group)
PHC Holdings Company (TOKYO: 6523) is a world healthcare firm with a mission of contributing to the well being of society by means of healthcare options which have a constructive impression and enhance the lives of individuals. Its subsidiaries (referred to collectively as PHC Group) embrace PHC Company, Epredia, Ascensia Diabetes Care, LSI Medience Company, Mediford, and Wemex. Collectively, these corporations develop, manufacture, promote and repair options throughout diabetes administration, healthcare options, life sciences and diagnostics. PHC Group’s consolidated internet gross sales in FY2023 have been JPY 353.9 billion with international distribution of services and products in additional than 125 nations.
www.phchd.com

View supply model on businesswire.com: https://www.businesswire.com/information/residence/20241211103952/en/

Contacts

Contact for media inquiries:
Julia Cottrill
PHC Holdings Company
E mail: julia.cottrill@phchd.com

Contact for product and repair:
Advertising and marketing Division, Biomedical Division PHC Company
E-mail: masayo.okada@phchd.com

#distro

Article content material